30-Second Takeaway
- Digital physician–pharmacist collaboration for T2D improves HbA1c, ASCVD risk, and diabetes costs in underresourced primary care.
- GLP-1 RA treatment for obesity without diabetes shows frequent switching and modest 12‑month persistence and adherence.
- Systematic postpartum depression screening nearly doubles observed prevalence and substantially shortens time to diagnosis.
Week ending March 14, 2026
Team-based care, access barriers, and focused behavioral interventions in everyday family practice
Digital physician–pharmacist collaboration improves glycemic control and ASCVD risk in T2D
This 12-month cluster RCT in six Chinese primary care clinics enrolled 574 adults with type 2 diabetes. The intervention added pharmacist counseling delivered via four in-person visits plus biweekly mobile health education to usual physician care. Compared with controls, intervention patients had greater HbA1c reduction (-2.57 vs -1.96 percentage points; P<.001) and larger 10-year ASCVD risk reduction (-1.35 vs 0.01). Fasting and 2-hour postprandial glucose, waist measures, blood pressure, triglycerides, and total cholesterol all improved more with the collaborative model.
GLP-1 RA regimens for obesity show frequent switching and modest persistence over 12 months
This US cohort study evaluated GLP-1 receptor agonist treatment patterns among adults with overweight or obesity but no diabetes. Investigators assessed 12-month switching, adherence, and persistence across GLP-1 agents used for weight management. About 65% of patients were adherent at 12 months, and only approximately 52% remained persistent on therapy. Frequent switching and discontinuation underscore the need to anticipate insurance, supply, tolerability, and cost barriers during obesity treatment planning.
Population postpartum depression screening improves detection and accelerates diagnosis
This retrospective cohort analyzed 19,234 women (20,448 births) across health areas in Bizkaia, Spain, from 2020–2023. A population-based postpartum depression screening program was compared with usual care in areas without structured screening. Screened women had higher raw PPD prevalence (7.4%) than unscreened women in the intervention area (4.1%) and non-intervention areas (4.4%). Screening independently increased PPD identification (HR 1.26; p=0.001) and shortened median time to diagnosis (105 vs 180–215 days).
Cost-related delayed or forgone care among Latino adults is associated with higher ED use
This cross-sectional analysis pooled 2019–2024 National Health Interview Survey data for 17,344 Latino adults aged 18–64 years. Overall, 16.9% reported cost-related delayed or forgone physical or mental health care in the prior year. Those reporting delayed or forgone care had higher odds of at least one ED visit (AOR 1.78; 95% CI 1.59–2.01) after adjustment. Higher ED use was also associated with female sex, lower education, public insurance, non-Mexican heritage, and poorer self-rated health.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.